Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease

ConditionCopd

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-75

SponsorCardenal Herrera University

About this trial

The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

COPD;

Forced expiratory volume in the first second (FEV1) < 80%;

FEV1/Forced vital capacity (FVC) < 70%;

Maximal inspiratory pressure (MIP) < 70%.

Disqualifiers

Recent (6 months) spine or abdominal surgery;

Allergic status of any kind;

systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);

neuromuscular or neurological injuries;

Trial design

Design model

Parallel

Treatments tested in this trial

Experimental-Myofascial + Respiratory rehabilitation
Other intervention
6 sessions of: Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)
Sham Myofascial + Respiratory rehabilitation
Other intervention
6 sessions of: Sham Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)

Treatment groups

30 Participants

are divided into 2 treatment groups

Group A: Sham Myofascial + Respiratory rehabilitationSham comparator 1 intervention

Group B: Experimental-Myofascial + Respiratory rehabilitationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Quality of life measured with the Chronic Obstructive Pulmonary Disease Assessment Test: Score

Score (0-40) higher scores mean a worse outcome.

Time frame

3 weeks

Secondary outcomes

6 Minutes Walking Test

Maximum distance reached

Time frame

3 weeks

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cardenal Herrera University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: